OLK
Closed
Olink Holding Ab Adr
26.08
+0.08 (+0.31%)
Last Update: 10 Jul 2024 16:30:00
Yesterday: 26.
Day's Range: 26.08 - 26.08
Send
sign up or login to leave a comment!
When Written:
21.71
Olink Holding AB is a Swedish biotechnology company that develops and provides innovative solutions for protein biomarker discovery and development. The company's products and services are used in research, clinical diagnostics, and drug development. Olink's technology enables highly multiplexed protein analysis with high sensitivity and specificity, making it possible to detect and quantify thousands of proteins in a single sample. The company's flagship product, the Olink Explore platform, allows researchers to analyze over 1,000 proteins in a single sample, providing a comprehensive view of the molecular mechanisms underlying disease. Olink Holding AB is listed on the NASDAQ Global Select Market under the ticker symbol "OLK." As of September 2021, Olink Holding AB's ADRs were trading at around $33.50 per share.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!
When Written:
21.71
Olink Holding AB is a Swedish biotech company that specializes in developing innovative solutions for protein biomarker discovery and analysis. The company's proprietary technology, called Proximity Extension Assay (PEA), allows for highly sensitive and specific detection of protein biomarkers in complex biological samples.
Olink Holding AB is listed on the NASDAQ Stockholm exchange under the ticker symbol OLK. The company also has an American Depositary Receipt (ADR) program, which allows U.S. investors to trade Olink Holding AB shares on the over-the-counter (OTC) market under the ticker symbol OLKLY. Each ADR represents one ordinary share of Olink Holding AB.
As of September 2021, Olink Holding AB has a market capitalization of approximately $5.7 billion and operates in over 60 countries worldwide. The company's products and services are used by academic and clinical researchers, pharmaceutical and biotech companies, and diagnostic laboratories to advance the understanding and treatment of a wide range of diseases, including cancer, cardiovascular disease, and neurological disorders.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Olink Holding AB is listed on the NASDAQ Stockholm exchange under the ticker symbol OLK. The company also has an American Depositary Receipt (ADR) program, which allows U.S. investors to trade Olink Holding AB shares on the over-the-counter (OTC) market under the ticker symbol OLKLY. Each ADR represents one ordinary share of Olink Holding AB.
As of September 2021, Olink Holding AB has a market capitalization of approximately $5.7 billion and operates in over 60 countries worldwide. The company's products and services are used by academic and clinical researchers, pharmaceutical and biotech companies, and diagnostic laboratories to advance the understanding and treatment of a wide range of diseases, including cancer, cardiovascular disease, and neurological disorders.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!